Lexeo Therapeutics Stock Quote LXEO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

12.55

Bid

11.40

Ask

13.10

Volume

196,751

12.27 Day's Range 12.86

9.00 52 Week Range 22.33

Market Cap

413.464M

Previous Close

12.72

Open

12.86

Last Trade

12.6

Last Trade Time

Financial Volume

$ 2,472,079

VWAP

12.5645

Average Volume (3m)

299,679

Shares Outstanding

32,945,341

Dividend Yield

PE Ratio

-6.24

Earnings Per Share (EPS)

-2.02

Revenue

Net Profit

-66.39M

Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.lexeotx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Lexeo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker LXEO. The last closing price for Lexeo Therapeutics was $12.72. Over the last year, Lexeo Therapeutics shares have traded in a share price range of $ 9.00 to $ 22.33.

Lexeo Therapeutics currently has 32,945,341 shares outstanding. The market capitalization of Lexeo Therapeutics is $419.06 million. Lexeo Therapeutics has a price to earnings ratio (PE ratio) of -6.24.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.76	6.44614079729	11.79	12.99	11.36	419470	12.18358211	CS
4	-1.23	-8.9259796807	13.78	19.5	10.9	516302	13.70401108	CS
12	-0.75	-5.63909774436	13.3	19.5	10.9	299679	14.71413693	CS
26	-4.33	-25.6516587678	16.88	19.5	10.9	198536	14.62685888	CS
52	3.05	32.1052631579	9.5	22.33	9	176774	14.24943259	CS
156	3.05	32.1052631579	9.5	22.33	9	176774	14.24943259	CS
260	3.05	32.1052631579	9.5	22.33	9	176774	14.24943259	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NCNCnoco noco Inc	$ 0.28 (83.01%)	299.33M
WINTWindtree Therapeutics Inc	$ 9.19 (61.80%)	682.87k
NUZENuZee Inc	$ 5.915 (59.86%)	36.61M
PMECPrimech Holdings Ltd	$ 0.8299 (57.72%)	99.13M
LSHLakeside Holding Ltd	$ 3.70 (56.12%)	28.51M
CETUUCetus Capital Acquisition Corporation	$ 2.60 (-62.86%)	3.1k
CETUCetus Capital Acquisition Corporation	$ 2.22 (-62.18%)	537.72k
IMNNImunon Inc	$ 1.33 (-59.94%)	16.24M
FGENFibroGen Inc	$ 0.5417 (-47.41%)	16.48M
VCNXVaccinex Inc	$ 5.09 (-36.85%)	1.06M
NVDANVIDIA Corporation	$ 117.02 (12.81%)	473.3M
NCNCnoco noco Inc	$ 0.28 (83.01%)	299.33M
SQQQProShares UltraPro Short QQQ	$ 8.59 (-8.91%)	244.35M
PRSTPresto Technologies Inc	$ 0.038406 (9.73%)	207.14M
FFIEFaraday Future Intelligent Electric Inc	$ 0.343 (8.54%)	145.24M